First Quadrant’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,909
| Closed | -$620K | – | 866 |
|
|
2020
Q1 | $620K | Sell |
6,909
-3,808
| -36% | -$342K | 0.09% | 228 |
|
|
2019
Q4 | $1.16M | Buy |
10,717
+707
| +7% | +$76.5K | 0.1% | 206 |
|
|
2019
Q3 | $980K | Sell |
10,010
-11,316
| -53% | -$1.11M | 0.09% | 232 |
|
|
2019
Q2 | $2.79M | Buy |
21,326
+14,417
| +209% | +$1.89M | 0.19% | 132 |
|
|
2019
Q1 | $934K | Sell |
6,909
-588
| -8% | -$79.5K | 0.07% | 275 |
|
|
2018
Q4 | $730K | Hold |
7,497
| – | – | 0.06% | 279 |
|
|
2018
Q3 | $1.04M | Hold |
7,497
| – | – | 0.02% | 386 |
|
|
2018
Q2 | $931K | Buy |
7,497
+2,400
| +47% | +$298K | 0.02% | 410 |
|
|
2018
Q1 | $568K | Sell |
5,097
-2,531
| -33% | -$282K | 0.01% | 475 |
|
|
2017
Q4 | $912K | Sell |
7,628
-155,891
| -95% | -$18.6M | 0.02% | 453 |
|
|
2017
Q3 | $22.9M | Sell |
163,519
-7,927
| -5% | -$1.11M | 0.44% | 63 |
|
|
2017
Q2 | $20.9M | Buy |
+171,446
| New | +$20.9M | 0.42% | 72 |
|
|
2015
Q2 | – | Sell |
-149,000
| Closed | -$25.8M | – | 816 |
|
|
2015
Q1 | $25.8M | Buy |
149,000
+148,000
| +14,800% | +$25.6M | 0.54% | 57 |
|
|
2014
Q4 | $185K | Buy |
+1,000
| New | +$185K | ﹤0.01% | 536 |
|
|
2014
Q3 | – | Sell |
-13,676
| Closed | -$2.14M | – | 849 |
|
|
2014
Q2 | $2.14M | Sell |
13,676
-77,000
| -85% | -$12M | 0.05% | 303 |
|
|
2014
Q1 | $13.8M | Buy |
90,676
+43,600
| +93% | +$6.63M | 0.31% | 100 |
|
|
2013
Q4 | $6.26M | Hold |
47,076
| – | – | 0.15% | 172 |
|
|
2013
Q3 | $5.47M | Buy |
+47,076
| New | +$5.47M | 0.14% | 183 |
|